当前位置：
X-MOL 学术
›
Am. J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer: A Retrospective Cohort Study.
American Journal of Clinical Oncology ( IF 2.6 ) Pub Date : 2021-05-24 , DOI: 10.1097/coc.0000000000000835 Takatsugu Ogata 1 , Yukiya Narita 1 , Ryosuke Kumanishi 1 , Taiko Nakazawa 1 , Yuki Matsubara 1 , Kyoko Kato 1 , Kazuki Nozawa 1 , Kazunori Honda 1 , Toshiki Masuishi 1 , Hideaki Bando 1 , Shigenori Kadowaki 1 , Masashi Ando 1 , Masahiro Tajika 2 , Kei Muro 1
American Journal of Clinical Oncology ( IF 2.6 ) Pub Date : 2021-05-24 , DOI: 10.1097/coc.0000000000000835 Takatsugu Ogata 1 , Yukiya Narita 1 , Ryosuke Kumanishi 1 , Taiko Nakazawa 1 , Yuki Matsubara 1 , Kyoko Kato 1 , Kazuki Nozawa 1 , Kazunori Honda 1 , Toshiki Masuishi 1 , Hideaki Bando 1 , Shigenori Kadowaki 1 , Masashi Ando 1 , Masahiro Tajika 2 , Kei Muro 1
Affiliation
Insufficient oral intake in advanced gastric cancer (AGC) limits the use of several drugs. We aimed to determine the oral intake status of patients with AGC during later-line chemotherapy.
中文翻译：
口服摄入量对 589 名晚期胃癌患者二线或三线化疗的临床影响：一项回顾性队列研究。
晚期胃癌 (AGC) 的口服摄入不足限制了几种药物的使用。我们旨在确定 AGC 患者在后期化疗期间的口服摄入状态。
更新日期：2021-05-26
中文翻译：
口服摄入量对 589 名晚期胃癌患者二线或三线化疗的临床影响：一项回顾性队列研究。
晚期胃癌 (AGC) 的口服摄入不足限制了几种药物的使用。我们旨在确定 AGC 患者在后期化疗期间的口服摄入状态。
京公网安备 11010802027423号